Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.09
(0.04%)
USD 25.09
(0.04%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 183.17 Million USD | 75.83% |
| 2022 | 104.17 Million USD | 34.11% |
| 2021 | 77.67 Million USD | 307.81% |
| 2020 | 19.04 Million USD | 2.5% |
| 2019 | 18.58 Million USD | 54.87% |
| 2018 | 11.99 Million USD | -18.53% |
| 2017 | 14.72 Million USD | 59.14% |
| 2016 | 9.25 Million USD | 11.01% |
| 2015 | 8.33 Million USD | 43852.97% |
| 2014 | 18.96 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 1.05 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 184.14 Million USD | 0.53% |
| 2024 Q2 | 185.02 Million USD | 0.48% |
| 2023 Q2 | 169.71 Million USD | 0.51% |
| 2023 Q4 | 183.17 Million USD | 0.54% |
| 2023 Q3 | 182.18 Million USD | 7.35% |
| 2023 FY | 183.17 Million USD | 75.83% |
| 2023 Q1 | 168.85 Million USD | 62.08% |
| 2022 Q4 | 104.17 Million USD | 30.61% |
| 2022 Q3 | 79.75 Million USD | 0.02% |
| 2022 Q2 | 79.74 Million USD | 1.36% |
| 2022 FY | 104.17 Million USD | 34.11% |
| 2022 Q1 | 78.67 Million USD | 1.29% |
| 2021 FY | 77.67 Million USD | 307.81% |
| 2021 Q4 | 77.67 Million USD | 2.08% |
| 2021 Q1 | 17.5 Million USD | -8.08% |
| 2021 Q3 | 76.09 Million USD | 0.15% |
| 2021 Q2 | 75.97 Million USD | 333.94% |
| 2020 Q4 | 19.04 Million USD | -4.57% |
| 2020 Q2 | 20.17 Million USD | 13.08% |
| 2020 Q3 | 19.96 Million USD | -1.07% |
| 2020 Q1 | 17.84 Million USD | -3.99% |
| 2020 FY | 19.04 Million USD | 2.5% |
| 2019 Q4 | 18.58 Million USD | -0.85% |
| 2019 Q2 | 19.5 Million USD | 11.66% |
| 2019 Q1 | 17.46 Million USD | 45.56% |
| 2019 FY | 18.58 Million USD | 54.87% |
| 2019 Q3 | 18.74 Million USD | -3.9% |
| 2018 Q1 | 14.41 Million USD | -2.15% |
| 2018 Q4 | 11.99 Million USD | -5.28% |
| 2018 Q3 | 12.66 Million USD | -7.11% |
| 2018 Q2 | 13.63 Million USD | -5.38% |
| 2018 FY | 11.99 Million USD | -18.53% |
| 2017 FY | 14.72 Million USD | 59.14% |
| 2017 Q4 | 14.72 Million USD | -0.22% |
| 2017 Q3 | 14.76 Million USD | 14.54% |
| 2017 Q2 | 12.88 Million USD | 79.17% |
| 2017 Q1 | 7.19 Million USD | -22.29% |
| 2016 Q4 | 9.25 Million USD | -17.14% |
| 2016 FY | 9.25 Million USD | 11.01% |
| 2016 Q2 | 9.41 Million USD | 3.45% |
| 2016 Q3 | 11.16 Million USD | 18.66% |
| 2016 Q1 | 9.09 Million USD | 9.14% |
| 2015 Q3 | 8.21 Million USD | 1.85% |
| 2015 FY | 8.33 Million USD | 43852.97% |
| 2015 Q1 | 12 Thousand USD | -36.74% |
| 2015 Q2 | 8.06 Million USD | 67141.67% |
| 2015 Q4 | 8.33 Million USD | 1.45% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 18.96 Thousand USD | -24.41% |
| 2014 Q3 | 25.09 Thousand USD | 146.77% |
| 2014 Q2 | 10.16 Thousand USD | 0.0% |
| 2014 FY | 18.96 Thousand USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q1 | 1.07 Million USD | 1.75% |
| 2011 FY | - USD | -100.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 FY | 1.05 Million USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | 1.05 Million USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 19.93 Thousand USD | -918700.161% |
| BIMI International Medical Inc. | 2.88 Million USD | -6239.147% |
| China Jo-Jo Drugstores, Inc. | 6.4 Million USD | -2760.338% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 0.0% |
| Leafly Holdings, Inc. | 29.08 Million USD | -529.782% |
| Leafly Holdings, Inc. | 29.08 Million USD | -529.782% |
| LifeMD, Inc. | 17.92 Million USD | -921.725% |
| LifeMD, Inc. | 17.92 Million USD | -921.725% |
| TRxADE HEALTH, Inc. | 434.2 Thousand USD | -42085.604% |
| PetMed Express, Inc. | 995 Thousand USD | -18309.246% |
| Walgreens Boots Alliance, Inc. | 8.04 Billion USD | 97.723% |